Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is cutaneous (skin) lymphoma?
Cutaneous lymphoma is a type of lymphoma — a cancer of immune system cells — that begins in the skin instead of in the lymph nodes or blood. The most common form, mycosis fungoides, is a slow-growing T-cell lymphoma that often behaves more like a chronic skin condition than a fast-moving cancer, sometimes lasting many years and frequently mistaken early on for eczema or psoriasis. It typically appears as flat patches, raised plaques, or, in more advanced cases, thicker tumors or widespread redness of the skin. A related, more advanced form called Sézary syndrome involves the skin along with the blood and lymph nodes. Because the disease lives in the skin, treatment is often directed at the skin itself, and radiation is one of the most effective tools available: it can clear individual spots completely and, in a specialized form, treat the entire skin surface at once. Most people with early cutaneous lymphoma have an excellent outlook and a normal or near-normal life expectancy, with treatment aimed at controlling the disease and relieving symptoms such as itching rather than at aggressive cure. Care is usually shared by dermatologists, radiation oncologists, and lymphoma specialists.
The main types
Doctors group cutaneous (skin) lymphoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Mycosis fungoides | The most common cutaneous lymphoma — a slow-growing T-cell lymphoma that appears as patches and plaques on the skin and is often present for years; radiation is highly effective for its lesions. |
| Sézary syndrome | A more advanced, aggressive form involving the skin, blood, and lymph nodes, often causing widespread skin redness and intense itching; treated with whole-body and systemic therapies. |
| Primary cutaneous B-cell lymphomas | A group of skin lymphomas arising from B-cells rather than T-cells; many are very indolent and respond beautifully to local radiation, which is often the preferred treatment. |
| CD30-positive cutaneous lymphomas | Skin lymphomas (such as primary cutaneous anaplastic large cell lymphoma) marked by a protein called CD30; localized lesions often respond very well to radiation, and targeted drugs are available for broader disease. |
Staging, in plain terms
Cutaneous lymphoma uses a specialized staging system that adds a fourth letter — B for blood — to the usual TNM. T describes how much skin is involved and what kind of lesions are present (limited patches, more extensive patches and plaques, thicker tumors, or widespread skin redness). N describes whether lymph nodes are involved, M whether there is spread to internal organs, and B whether lymphoma cells are present in the blood. These combine into stages from IA, where only a small area of skin is affected, up to IVB. The key practical divide is between early-stage disease limited to the skin — which is common, slow-growing, and managed with skin-directed treatments including radiation — and advanced-stage disease involving the blood, nodes, or organs, which calls for whole-body and systemic therapies. Most patients are diagnosed at an early stage and do very well.
| TNMB system (skin, nodes, metastasis, blood), stages IA–IVB | What it generally means |
|---|---|
| Stage IA–IB | Patches or plaques limited to the skin, covering a smaller (IA) or larger (IB) area, with no node, blood, or organ involvement; managed with skin-directed treatments such as creams, light therapy, and radiation. |
| Stage IIA–IIB | More extensive skin involvement or the appearance of thicker skin tumors; radiation is especially useful for clearing tumors, alongside skin-directed and sometimes systemic therapy. |
| Stage III | Widespread redness of most of the skin; treated with whole-skin and systemic approaches to control the disease and relieve symptoms. |
| Stage IV | Involvement of lymph nodes, blood (as in Sézary syndrome), or internal organs; treated with systemic and combined therapies, with radiation used to relieve troublesome spots. |
The standard of care
Cutaneous (Skin) Lymphoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Skin-directed therapies
Early disease is often controlled with treatments applied to the skin — steroid or other medicated creams, ultraviolet light therapy, and radiation — which can clear lesions while sparing the rest of the body.
Radiation therapy
Radiation is one of the most effective treatments for cutaneous lymphoma: low doses can clear individual spots, and a specialized technique can treat the entire skin surface; it works because these lymphomas are very radiation-sensitive.
Total skin electron beam therapy (TSEBT)
A unique radiation method that treats the whole skin surface using electrons that penetrate only the skin, controlling widespread disease while sparing the internal organs.
Systemic therapies
For advanced disease or blood involvement, treatments that work throughout the body — such as targeted antibodies, immune-modulating drugs, or chemotherapy — are used to control the lymphoma.
Symptom relief and skin care
Because itching and skin discomfort are common, managing symptoms and caring for the skin barrier are important parts of treatment and quality of life.
How radiation treatment works
Radiation uses focused energy to damage the DNA inside cancer cells so they can no longer grow and divide, and cutaneous lymphoma is among the most radiation-sensitive of all cancers — meaning even low doses are remarkably effective. Because the disease lives in the skin, radiation can be aimed precisely at the skin without affecting deeper organs. For an individual patch, plaque, or tumor, a small number of low-dose sessions can clear the lesion completely. For more widespread skin disease, a specialized technique called total skin electron beam therapy treats the entire surface of the body: it uses electrons, a form of radiation that penetrates only a short distance, so the dose is delivered to the skin while the internal organs are spared. These whole-skin treatments can even be repeated over time, at lower doses, to manage disease that comes back. Radiation is also a fast, reliable way to relieve a spot that is painful, itchy, or ulcerated. Because cutaneous lymphoma is usually a chronic, slow-growing condition, the goal of radiation is typically to control the disease and improve comfort and appearance rather than to deliver harsh treatment. Your radiation oncologist, working with your dermatologist and lymphoma specialist, will choose the dose and technique to match how much skin is involved and how you are feeling.
The main ways radiation is delivered for cutaneous (skin) lymphoma:
Localized low-dose radiation
A small number of low-dose radiation sessions can completely clear an individual patch, plaque, or tumor; because the lymphoma is so radiation-sensitive, even gentle doses are highly effective.
Total skin electron beam therapy (TSEBT)
Electrons are aimed at the entire skin surface and deposit their energy only in the skin's depth, treating widespread disease across the whole body while sparing internal organs.
Low-dose TSEBT and repeat courses
Lower-dose whole-skin treatments can be given and, because they spare deeper tissue, repeated over time to control recurring disease while limiting side effects.
Palliative radiation for symptomatic spots
When a particular lesion is painful, itchy, or ulcerated, a short course of focused radiation can relieve symptoms quickly and reliably.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Low-dose radiation clears lesions effectively: Research showed that very low radiation doses can completely clear cutaneous lymphoma lesions, allowing effective treatment with minimal side effects and the ability to re-treat if needed.[1]
Low-dose radiation cutaneous lymphoma studies
Low-dose total skin electron beam therapy: Studies established that lower-dose whole-skin radiation controls widespread disease with fewer side effects than traditional higher doses and can be repeated over a patient's lifetime.[2]
TSEBT dose-reduction trials
Targeted antibodies for advanced disease: Newer targeted antibody therapies have improved control of advanced cutaneous T-cell lymphoma, expanding options for patients with blood or node involvement, often alongside skin-directed radiation.[3]
Cutaneous T-cell lymphoma systemic therapy trials
Common questions
Is cutaneous lymphoma a serious cancer? Most people have an early, slow-growing form — especially mycosis fungoides — that behaves more like a chronic skin condition than an aggressive cancer, with an excellent outlook and often a normal or near-normal life expectancy. Treatment focuses on controlling the disease and relieving symptoms. A minority have more advanced disease that needs whole-body therapy.
How can radiation treat my whole skin without harming my organs? A technique called total skin electron beam therapy uses electrons, which penetrate only a short distance into the skin. This delivers the radiation dose to the skin across your entire body while sparing the internal organs underneath. It can even be repeated at lower doses over time.
Will the lymphoma come back after radiation? Cutaneous lymphoma is often a chronic condition that can return over time, but it usually responds again to treatment. Radiation can be used repeatedly — individual spots can be re-treated, and whole-skin therapy can be given more than once at lower doses — to keep the disease under control.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.